MAINOLFI NELLO (President and CEO) sold 4.3% of their position (30K shares) of KYMERA THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.44M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 4/29/2026ACC: 0001193125-26-192146
DirectorOfficer· President and CEO
Since Aug 2020
-30K
Net shares
Net seller
$2.44M
Total sold
3
Open market trades
0B · 3S
5
Total transactions
30K acquired · 60K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+30K
Price / share
$2.08
Trade value
$62.40K
% of position
4.5%
4/29/2026
666.20K→696.20K
Common Stock
Direct
Shares
−17K
Price / share
$80.74
Trade value
$1.37M
% of position
2.4%
4/29/2026
696.20K→679.19K
Common Stock
Direct
Shares
−12.06K
Price / share
$81.70
Trade value
$985.22K
% of position
1.8%
4/29/2026
679.19K→667.13K
Common Stock
Direct
Shares
−936.00
Price / share
$82.45
Trade value
$77.17K
% of position
0.1%
4/29/2026
667.13K→666.20K
Total
Net shares
+0.00
Net value
-$2.37M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/29/2026 | M · Option Exercise | +30K | $2.08 | $62.40K | 4.5% | 666.20K | 696.20K |
| Common Stock Direct | 4/29/2026 | S · Sale | −17K | $80.74 | $1.37M | 2.4% | 696.20K | 679.19K |
| Common Stock Direct | 4/29/2026 | S · Sale | −12.06K | $81.70 | $985.22K | 1.8% | 679.19K | 667.13K |
| Common Stock Direct | 4/29/2026 | S · Sale | −936.00 | $82.45 | $77.17K | 0.1% | 667.13K | 666.20K |
| Total | +0.00 | -$2.37M | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
30K shares
Shares
−30K
Strike price
2.08
Held after
215.56K
Exercisable
—
4/29/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock30K shares | 4/29/2026 | M · Option Exercise | −30K | 2.08 | — | 215.56K |